Resources Contact Us Home
Ribonucleotide reductase inhibitors and methods of use

Image Number 17 for United States Patent #8372983.

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

  Recently Added Patents
Dual use photovoltaic system
Real-time RSL monitoring in a web-based application
Rear bumper for an automobile
Cytokine biomarkers as predictive biomarkers of clinical response for Glatiramer acetate
Analysis device and an analysis apparatus using the analysis device
Organic electroluminescence device
Improving alignment target contrast in a lithographic double patterning process
  Randomly Featured Patents
Education system kit
Inductive or capacitive detector
Cooling fan with spray function
Self aligning press in bearing structures
Compressor airfoil surface wetting and icing detection system
Charge coupling for electric vehicle
Dual throat data registering apparatus and card therefor
Error concealment in relation to decoding of encoded acoustic signals
Method of determining the position of a medical instrument
Signal processing device, signal processing method, program, and recording medium